相关实验视频
Updated: Jul 14, 2025

07:04
Identifying PD-1/PD-L1 Inhibitors with Surface Plasmon Resonance Technology
Published on: May 2, 2025
393
针对抗体的免疫检查点对结合性癌症治疗有希望
Ritu1, Prakash Chandra1, Asmita Das2
1Department of Biotechnology, Delhi Technological University, Main Bawana Road, New Delhi, 110042, India.
Clinical and experimental medicine
|October 7, 2023
概括
免疫疗法通过增强免疫系统来增强癌症治疗,但瘤异质性带来了挑战. 这项研究审查了免疫调节抗体试验,以改善癌症治疗和患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 免疫疗法是一种成功的癌症治疗方式,它增强了免疫系统向瘤细胞的能力.
- 瘤异质性通过破坏抗瘤免疫反应和操纵瘤微环境而构成挑战.
- 免疫调节抗体被批准抑制免疫检查点,帮助向和组合疗法.
研究的目的:
- 提供正在进行的临床试验使用免疫调节抗体在各种癌症类型的全面概述.
- 探索这些抗体在调节免疫系统和增强抗瘤反应方面的潜力.
- 讨论免疫调节疗法在癌症治疗中的未来前景.
主要方法:
- 关于在癌症治疗中使用免疫调节抗体的临床试验的审查.
- 分析这些抗体调节免疫系统和瘤微环境的机制.
- 探索当前关于组合疗法和新型免疫调节策略的研究.
主要成果:
- 免疫调节抗体在增强抗瘤免疫力和改善各种癌症治疗结果方面表现有前途.
- 确定瘤微环境中的关键点对于有效的组合疗法至关重要.
- 目前正在进行的临床试验正在评估各种基于免疫调节抗体的治疗方法的疗效和安全性.
结论:
- 免疫疗法,特别是免疫调节抗体,为推进癌症治疗提供了显著的潜力.
- 平衡免疫激活和调节对于最大限度地提高治疗效益和最大限度地减少不良影响至关重要.
- 对免疫调节抗体的进一步研究将加深我们对免疫瘤相互作用的理解,并改善患者护理.
相关概念视频
Tumor Immunotherapy
544
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
544
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Vaccines
389
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
389
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K

